Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2007, p. 2988-2990, Vol. 51, No. 8
0066-4804/07/$08.00+0 doi:10.1128/AAC.00083-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Dipartimento di Scienze e Tecnologie Biomediche, Università di L'Aquila, I-67100 L'Aquila,1 Dipartimento di Biologia Molecolare, Laboratorio di Fisiologia e Biotecnologia dei Microrganismi, Università di Siena, I-53100 Siena,2 Dipartimento di Scienze Microbiologiche e Ginecologiche, Università di Catania, I-95124 Catania, Italy3
Received 19 January 2007/ Returned for modification 9 March 2007/ Accepted 20 April 2007
|
|
|---|
|
|
|---|
The aim of this study was to characterize a novel IND-type MBL variant, IND-5, identified in a clinical isolate of C. indologenes from an Italian hospital.
(Part of this work was presented at the 16th European Congress of Clinical Microbiology and Infectious Diseases, abstr. 934, 2006.)
C. indologenes NF16 (CDC group Iib) was isolated from the sputum of a patient at the Hematology Unit of Ferrarotto Hospital (Catania, southern Italy). Genomic and plasmidic DNAs were purified as previously described (9). In order to amplify the blaIND gene and its flanking regions from genomic DNA, the following primers were used: INDA_for, 5'GGGCATATGAAAAAAAGAATTCAGTTCTTTA; INDB_for, 5'GGGGATATCATGAAAAAAAGAATTCAGTTCTTTA; and IND_rev, 5'GGGGGATCCTTATTTTTTGTTAAGAAGTTCAAGA (boldface type indicates the NdeI, EcoRV, and BamHI restriction sites, respectively, in the three primers). Amplicons obtained by PCR using INDA_for and IND_rev were cloned into pET-9a (Novagen, Inc., Madison, WI) vectors, whereas amplicons obtained using INDB_for and IND_rev were cloned into pBC-SK (Stratagene, Inc., La Jolla, CA) vectors. The recombinant plasmids, named pET-IND-5 and pBC-IND-5, were introduced by transformation into Escherichia coli BL21(DE3) and HB101 competent cells, respectively. The fidelity of the cloned fragments was confirmed by sequencing both strands. Conjugation experiments were carried out using Escherichia coli K-12 as a recipient and at an initial donor/recipient ratio of 0.1. Transconjugants were selected on Mueller-Hinton agar containing streptomycin (1,000 µg/ml) and imipenem (2 µg/ml).
In vitro susceptibility testing was performed by agar dilution using a bacterial inoculum of 5 x 105 CFU per spot according to CLSI guidelines (2). E. coli ATCC 25922 was used as a quality control strain for antimicrobial susceptibility testing.
IND-5 was purified from 2 liters of E. coli BL21(DE3)/pET-IND-5 grown at 37°C for about 6 h (A600 = 0.8) and for a further 2 h at 20°C after induction with 1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside). The bacterial suspension was pelleted, resuspended in 40 ml of 50 mM HEPES (pH 7.5) plus 50 µM ZnSO4, sonicated (five cycles at 30 W for 30 s each time), and centrifuged for 30 min at 105,000 x g at 4°C. The cleared extract was loaded onto a Mono Q Sepharose column equilibrated with 20 mM ethanolamine buffer (pH 8.6) plus 50 µM ZnSO4. The active fractions were eluted during the washing step, whereas the remaining proteins (about 77%) bound to the column. The active fractions were dialyzed against 0.025 M diethanolamine buffer (pH 9.0) plus 50 µM ZnSO4 and loaded onto a Mono P HR 5/20 column. The enzyme was eluted with 1:10 Polybuffer 96 (pH range, 9.0 to 6.0). At the end of each purification step, the ß-lactamase activity was tested by measuring the hydrolysis of 200 µM imipenem using 50 mM HEPES (pH 7.5) plus 50 µM ZnSO4. The Mr and pI values of IND-5 were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (4) and isoelectric focusing analysis (6), respectively. Steady-state kinetic parameters (Km and kcat) were determined for purified enzyme by measuring substrate hydrolysis under initial rate conditions and by using the Hanes linearization of the Michaelis-Menten equation as described previously (11) with 30 mM sodium cacodylate buffer (pH 6.5) plus 50 µM ZnSO4. The thermal stability of the IND-5 enzyme was determined by measuring the hydrolysis of 200 µM imipenem after incubation of the enzyme at 40°C for a maximum of 120 min, at 45°C for a maximum of 90 min, and at 55°C for a maximum of 60 min. The interaction with the chelating agents EDTA, 1,10-o-phenanthroline, and pyridine-2,6-dicarboxylic (dipicolinic) acid was determined by incubating 0.1 µM enzyme at 30°C for 15 min with increasing inhibitor concentrations and using 100 µM nitrocefin as a reporter substrate (3).
The C. indologenes NF16 clinical isolate was resistant to carbapenems and intermediate to cefotaxime but appeared to be susceptible to piperacillin, piperacillin-tazobactam, ceftazidime, cefepime, and aztreonam (Table 1).
|
View this table: [in a new window] |
TABLE 1. Pattern of resistance mediated by the IND-5 metallo-ß-lactamase gene in E. coli and C. indologenes strains
|
![]() View larger version (64K): [in a new window] |
FIG. 1. Amino acid sequence of the IND-5 (corresponding to GenBank accession number AY504627) metallo-ß-lactamase compared to those of IND-1 (AF099139), IND-2 (AF219129), IND-2a (AF219130), IND-3 (AF219133), and IND-4 (AF219135). Dots indicate identical amino acids. Shading indicates conserved residues in carbapenem-hydrolyzing ß-lactamases.
|
IND-5 was purified from E. coli BL21(DE3)/pET-IND-5 by two chromatographic steps. The protein preparation was estimated to be >95% pure, as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (data not shown). The Mr and pI values of IND-5 were estimated to be 25,000 and 8.8, respectively, in accordance with theoretical calculations (Mr 24,535 and pI 8.89).
As shown in Table 2, the IND-5 enzyme was able to hydrolyze amino-, carboxy-, and ureidopenicillins, cefazolin, cefotaxime, and carbapenems. Benzylpenicillin was the best substrate, showing a kcat/Km value about 57-fold and 35-fold higher than those of meropenem and imipenem, respectively. Hydrolysis of ceftazidime, cefepime, aztreonam, and moxalactam was not detectable. Two classical inactivators of active-site serine ß-lactamases that are in current clinical use have been investigated. Sulbactam was hydrolyzed by the IND-5 enzyme with a non-negligible hydrolysis (kcat/Km = 2.5 x 10–3 µM–1s–1), as previously observed with other zinc enzymes (7). Conversely, tazobactam was stable in the presence of this enzyme. Overall, kinetic data were consistent with the results of susceptibility testing when the IND-5 enzyme was expressed in E. coli (Table 1). Among IND-like enzymes, a comparison of the kinetic parameters of IND-5 is possible only with IND-2 and IND-1 (in the case of IND-1, it is possible to examine only the Km values) (1). It is interesting that the catalytic efficiencies of IND-2 toward imipenem and meropenem are about 25-fold and 13-fold higher than those of IND-5, respectively. We suggest that among the amino acid substitutions found in the IND-5 metallo-ß-lactamase, the residue at position 222 could be involved in the drastic reduction in catalytic efficiency of this enzyme relative to those of other IND-2 enzymes (1). The glutamic acid at position 222, strictly conserved in all IND-type ß-lactamases, is close to the histidine 220 residue (located at the Cys site) that is involved in the binding of the Zn(II).
|
View this table: [in a new window] |
TABLE 2. Kinetic parameters of purified IND-5 ß-lactamasea
|
The importance of chromosomal MBLs from the Flavobacteriaceae has been established in the last decade because of their involvement in resistance in pathogens like C. indologenes and Elizabethkingia meningoseptica. Further biochemical and molecular characterizations of different variants of these enzymes could be of interest to provide insight into their structure-function relationships.
Nucleotide sequence accession number. The nucleotide sequence of the blaIND-5 gene will appear in the GenBank database under accession number AY504627.
Published ahead of print on 30 April 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»